MEDALLIANCE
MedAlliance is a privately-owned medical technology company. MedAlliance develops innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease.
MEDALLIANCE
Industry:
Health Care Medical
Founded:
2008-01-01
Address:
Nyon, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.medalliance.com
Total Employee:
51+
Status:
Active
Contact:
+41 22 363 78 90
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Similar Organizations
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-03 | MDK Medical | MDK Medical acquired by MedAlliance | N/A |
Investors List
CITIC Capital Holdings
CITIC Capital Holdings investment in Private Equity Round - MedAlliance
Official Site Inspections
http://www.medalliance.com Semrush global rank: 8.92 M Semrush visits lastest month: 232
- Host name: 137.184.35.213
- IP address: 137.184.35.213
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "MedAlliance"
MedAlliance - Crunchbase Company Profile & Funding
MedAlliance is a privately-owned medical technology company. MedAlliance develops innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and …See details»
Cordis Announces Acquisition of MedAlliance
Oct 17, 2022 · By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLRâ„¢ (Sustained Limus Release) drug-eluting balloon. The agreement includes an initial investment of …See details»
Cordis Announces the Completed Acquisition of …
Oct 2, 2023 · Miami Lakes, FL - Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced that it has completed the acquisition of MedAlliance, a …See details»
MedAlliance Acquired by Cordis for up to USD 1.135 …
GENEVA, Switzerland, Oct. 2, 2023 /CNW/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of...See details»
MedAlliance Swiss Medical Technology - LinkedIn
Developing ground-breaking technology for the treatment of coronary and peripheral artery disease. Founded in 2008, MedAlliance is a privately-owned medical technology company. It is...See details»
Cordis finalizes deal to acquire MedAlliance for up to $1.1B
Oct 2, 2023 · Cordis has finalized its agreement to acquire MedAlliance, a Switzerland-based healthcare technology company focused on drug-eluting balloons, in a deal that could …See details»
MedAlliance acquired by Cordis for up to USD 1.135 billion
Oct 2, 2023 · Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together …See details»
MedAlliance Acquired by Cordis for USD 1.135 Billion
GENEVA, Oct. 2, 2023 /PRNewswire/ — Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing …See details»
MedAlliance Swiss Medical Technology | LinkedIn - LinkedIn Schweiz
Developing ground-breaking technology for the treatment of coronary and peripheral artery disease. Founded in 2008, MedAlliance is a privately-owned medical technology company. It is...See details»
MedAlliance Acquired by Cordis in Landmark Deal, …
Oct 6, 2023 · MedAlliance, a pioneering Swiss medical device startup, has been acquired by Cordis, a Johnson & Johnson company, in a landmark USD 1.135 billion deal. The acquisition, announced on October 6, 2023, is expected to …See details»
MedAlliance - Products, Competitors, Financials, Employees ...
MedAlliance is a medical technology company that focuses on developing medical products for the treatment of coronary and peripheral artery disease. Use the CB Insights Platform to …See details»
MedAlliance to be Acquired by Cordis - Newswire
Oct 18, 2022 · MedAlliance's innovative and revolutionary sustained sirolimus drug eluting balloon (DEB) program, SELUTION SLR â„¢ (Sustained Limus Release), provides a flagship product …See details»
MedAlliance - Overview, News & Similar companies - ZoomInfo
View MedAlliance (www.medalliance.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
MedAlliance, a Pioneering Medical Device Startup, acquired
[Geneva, Switzerland, Oct 6 th, 2023] – MedAlliance, the visionary Swiss-based medical technology company, is delighted to announce the successful acquisition by Cordis, a …See details»
MedAlliance Swiss Medical Technology - The Org
View MedAlliance Swiss Medical Technology's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
MedAlliance - Funding, Financials, Valuation & Investors
MedAlliance is funded by 2 investors. CITIC Capital Holdings and Trustar Capital are the most recent investors. MedAlliance has acquired MDK Medical on Feb 3, 2022.See details»
Trustar Capital Completes Investment in Global Medical …
Based global leading medical technology company MedAlliance SA (‘The Company’ or ‘MedAlliance’), becoming MedAlliance’s single largest shareholder. The investment will be …See details»
MedAlliance raises over USD 50 million to commercialize drug …
Mar 22, 2021 · MedAlliance, the first drug-eluting balloon company in the world to receive US FDA Breakthrough Device Designation Status for a sirolimus DEB, has recently been awarded …See details»
MedAlliance Announces Enrollment of over 1,660 Patients in
GENEVA, Sept. 14, 2023 /CNW/ -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now …See details»
MedAlliance announces enrollment of First Patient in ... - Newswire
Sep 5, 2023 · MedAlliance was the first drug-eluting balloon company to receive FDA Breakthrough Designation status. Currently three IDE clinical studies are evaluating …See details»